| Jennifer Hanna, MD | |
|
1701 N George Mason Dr, Arlington, VA 22205-3610 | |
| (703) 558-5000 | |
| Not Available |
| Full Name | Jennifer Hanna |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 34 Years |
| Location | 1701 N George Mason Dr, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821044157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0101055471 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
The health workers' unions of Queensland have rallied at Chermside to highlight the unresolved pay problems, and demand more recognition for the extra work and expertise involved in running the new payroll system.
For the first time in its history, Medicare will soon track spending on millions of individual beneficiaries, reward hospitals that hold down costs and penalize those whose patients prove most expensive. The administration plans to establish "Medicare spending per beneficiary" as a new measure of hospital performance, just like the mortality rate for heart attack patients and the infection rate for surgery patients.
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
While studying one of the smallest DNA viruses known, Sunnie Thompson, Ph.D., may have found a new way to help prevent kidney damage following organ transplant.
› Verified 7 days ago
| Entity Name | Dominion Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073554952 PECOS PAC ID: 7618863713 Enrollment ID: O20040305000503 |
News Archive
The health workers' unions of Queensland have rallied at Chermside to highlight the unresolved pay problems, and demand more recognition for the extra work and expertise involved in running the new payroll system.
For the first time in its history, Medicare will soon track spending on millions of individual beneficiaries, reward hospitals that hold down costs and penalize those whose patients prove most expensive. The administration plans to establish "Medicare spending per beneficiary" as a new measure of hospital performance, just like the mortality rate for heart attack patients and the infection rate for surgery patients.
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
While studying one of the smallest DNA viruses known, Sunnie Thompson, Ph.D., may have found a new way to help prevent kidney damage following organ transplant.
› Verified 7 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
The health workers' unions of Queensland have rallied at Chermside to highlight the unresolved pay problems, and demand more recognition for the extra work and expertise involved in running the new payroll system.
For the first time in its history, Medicare will soon track spending on millions of individual beneficiaries, reward hospitals that hold down costs and penalize those whose patients prove most expensive. The administration plans to establish "Medicare spending per beneficiary" as a new measure of hospital performance, just like the mortality rate for heart attack patients and the infection rate for surgery patients.
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
While studying one of the smallest DNA viruses known, Sunnie Thompson, Ph.D., may have found a new way to help prevent kidney damage following organ transplant.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Hanna, MD 255 W Michigan Ave, Jackson, MI 49201-2218 Ph: (800) 242-1131 | Jennifer Hanna, MD 1701 N George Mason Dr, Arlington, VA 22205-3610 Ph: (703) 558-5000 |
News Archive
The health workers' unions of Queensland have rallied at Chermside to highlight the unresolved pay problems, and demand more recognition for the extra work and expertise involved in running the new payroll system.
For the first time in its history, Medicare will soon track spending on millions of individual beneficiaries, reward hospitals that hold down costs and penalize those whose patients prove most expensive. The administration plans to establish "Medicare spending per beneficiary" as a new measure of hospital performance, just like the mortality rate for heart attack patients and the infection rate for surgery patients.
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
While studying one of the smallest DNA viruses known, Sunnie Thompson, Ph.D., may have found a new way to help prevent kidney damage following organ transplant.
› Verified 7 days ago
Robert Minh Cao Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1860 N Scott St Apt 639, Arlington, VA 22209 Phone: 337-534-9256 | |
Dr. Mushfique Ahmed, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-558-2438 | |
Dr. Krupa Bipin Patel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr Ste 2d, Arlington, VA 22205 Phone: 703-558-2438 | |
Marina Pavlova, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-558-5000 | |
John M Huffman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1635 N George Mason Dr Ste 150, Arlington, VA 22205 Phone: 571-732-0044 Fax: 866-850-1049 | |
Ashley Tran, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1701 N George Mason Dr Ste 2d, Arlington, VA 22205 Phone: 703-558-2438 | |
Dr. Peter Glass, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1525 Wilson Blvd Ste 540, Arlington, VA 22209 Phone: 202-315-5223 |